Stay updated on UBX1325 Safety in Macular Disease Clinical Trial
Sign up to get notified when there's something new on the UBX1325 Safety in Macular Disease Clinical Trial page.

Latest updates to the UBX1325 Safety in Macular Disease Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedAdded a dedicated Locations section listing California, Florida, Indiana, and Texas as study sites, and removed the individual state location sections for these states. Updated the page revision from v3.3.2 to v3.3.3 and removed the HHS Vulnerability Disclosure footer link.SummaryDifference0.6%

- Check24 days agoNo Change Detected
- Check45 days agoChange DetectedThe Publications note is updated to say PubMed publications are automatically filled and may not pertain to the study, replacing the former description. A Revision: v3.3.2 label is added.SummaryDifference0.1%

- Check52 days agoChange DetectedA maintenance notice about government funding and NIH operating status was removed from the page; it does not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check67 days agoChange DetectedThe screenshots show only minor formatting/UI changes with no edits to core study details such as inclusion criteria, outcomes, enrollment, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check95 days agoChange DetectedNew operating-status notice and version update to v3.2.0; previous v3.1.0 version tag removed.SummaryDifference5%

- Check102 days agoChange DetectedChanged the revision from v3.0.2 to v3.1.0, indicating a minor version update with no other content changes.SummaryDifference0.1%

Stay in the know with updates to UBX1325 Safety in Macular Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the UBX1325 Safety in Macular Disease Clinical Trial page.